Research News
Norris Cotton Cancer Center Researchers Win Awards in Promising Pursuit of “Most Wanted” Cancer Target
Researchers have identified a key and overlooked protein interaction that could lead to effective treatments for many cancers
Dartmouth-Hitchcock and Dartmouth’s Geisel School of Medicine Receive Grant to Monitor COVID-19 Variants in the Region
A team of researchers and clinicians at Geisel and DHMC has begun working together on a NIH grant to track the development and spread of COVID-19 variants in the Upper Valley.
D-H Nurse Scientist Awarded $20K Grant to Fund Innovative Remote Sleep Study
Cassandra M. Godzik, PhD, APRN, has been awarded a research grant from the Rockefeller University Heilbrunn Family Center for Research Nursing Scholars.
Groundbreaking Epilepsy Study to be Conducted at Dartmouth-Hitchcock Medical Center
Neurology Chair Barbara Jobst, MD, to Lead Dartmouth-Hitchcock in Study
Norris Cotton Cancer Center Researchers Discover How a Plant Virus Activates the Immune System Against Cancer
Immunology researchers led by Dartmouth and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have identified pathways through which cowpea mosaic virus, a plant virus that does not infect mammals, is recognized by the immune system.
Connect with the CEO with Joanne M. Conroy, MD, and Steven L. Bernstein, MD - Wednesday, June 9
Meet DHMC's new Chief Research Officer
Dartmouth and Dartmouth-Hitchcock Cancer Researchers Discover Cutting-Edge Approach to Fighting a Form of Deadly Cancer
Researchers at Norris Cotton Cancer Center have developed a way to predict chemotherapy response to tailor treatments for pancreatic cancer patients
Researchers at Norris Cotton Cancer Center Are Studying the Use of Estrogen to Target Drug-Resistant Breast Cancer
An ongoing clinical trial at NCCC will determine whether the strategy of cycling between estrogen therapy and anti-estrogen therapies is effective in human patients with advanced breast cancer.
Philanthropy-Backed Accelerator Advances Cancer Therapies
Three teams receive awards from the Dartmouth Innovations Accelerator for Cancer
Therapeutic Drug Studied at DHMC Proven Effective at Treating COVID-19
DHMC Only Hospital in New England to Take Part in Trial